-
Rising Kenyan lakes push crocodiles closer to homes
-
Pacific islands alarmed by Trump-backed push for deep-sea mining
-
Istanbul cymbals: From Ottoman war tool to pulse of global music
-
Erratic rains dictate menu at three-star Michelin restaurant in Brazil
-
Myanmar ex-junta chief on first Thailand trip as civilian leader
-
Zverev, Auger-Aliassime and Medvedev exit Montreal Masters
-
Environmental disaster looms as tanker leaks off Oman
-
Google-parent Alphabet shakes up AI division
-
Embattled Infantino sees minnows Malawi reach WAFCON quarter-finals
-
FIFA back Infantino, apologise for World Cup privatisation plan
-
Seeds Rybakina, Pegula and Gauff advance at WTA Toronto event
-
Auger-Aliassime out of Montreal ATP event with injury
-
Zverev, Auger-Aliassime exit star-short Montreal Masters
-
Colombian baby hippo of Escobar stock dies after rescue
-
Embattled FIFA chief Infantino in emergency talks in Morocco
-
Preakness shifts 2027 dates to entice more Derby horses
-
Castaway SpaceX rocket stage crashed into Moon, scientists say
-
Guatemalan volcano eruption ends, locals return home
-
Dow edges to record as markets parse prospects for Hormuz deal
-
WHO chief urges stronger Ebola response in DR Congo visit
-
Salah arrives in Turkey to complete Trabzonspor move
-
Newcastle appoint Jaissle as new head coach after Howe exit
-
AFP journalist to be honored at International Press Freedom Awards
-
Swiss ski star Lara Gut-Behrami calls time on 18-year career
-
Turkish MPs back limited amnesty for Kurdish militants
-
US indicts leaders of Mexico's CJNG cartel, ups reward money
-
Noosha Aubel: Czy poradzi sobie z problemami Poczdamu?
-
Noosha Aubel: Klarar hon av Potsdams problem?
-
Noosha Aubel: Είναι σε θέση να αντιμετωπίσει τα προβλήματα του Πότσδαμ;
-
Noosha Aubel: Zvládne problémy Postupimi?
-
نوشا أوبيل: هل هي على مستوى التحديات التي تواجهها بوتسدام؟
-
Former England fly-half Burns retires from rugby union
-
Brazil hits new diplomatic lows with US and Argentina
-
Pakistan beat West Indies by eight wickets to level series
-
NZ boxer Parker promises ring return after doping ban 'lifted'
-
Reusser holds lead as Vollering wins in Tour de France hills
-
Disney profits top estimates on strength in theme park business
-
Argentina's Albornoz hit with four-game ban for 'intimidatory' referee abuse
-
LIV Golf CEO says funding secured to play beyond 2026
-
Guatemala volcano eruption eases off, but alert remains in place
-
Stocks stall tracking earnings, oil dips on Iran-Oman Hormuz move
-
Baby hippo descended from Escobar's herd rescued in Colombia
-
Tuipulotu to lead New Zealand in South African tour opener
-
Woman arrested after four men stabbed in central London
-
Leftist Democrat urges unity after victory in Michigan
-
Celtic boss O'Neill in hospital after 'small procedure'
-
Austria, Slovakia hit new temperature records
-
Israeli forces raid Palestinian refugee camp near Jerusalem
-
Where mountain lions roam, fewer deer in the headlights
-
Explosive drone found near Ukrainian plane at German airport
Nobel winner's ingenious chemistry could lead to cancer breakthroughs
"All kinds of crazy things" is how Carolyn Bertozzi, a 2022 Nobel laureate, describes her life's work. Actually performing "chemistry in cells and in people."
When she started her research in 1997, the Stanford professor was aiming only to observe the evolution of certain molecules on the surface of cancer cells.
Today, thanks to her discoveries, at least two companies -- including one she co-founded -- are developing innovative cancer treatments.
The multitude of applications made possible by her findings are impressive: delivering treatments with extreme precision, understanding better how drugs act inside the body, visualizing certain bacteria, to name a few.
"I can't even really enumerate them. The vast majority of those applications I would never have foreseen," she told AFP in an interview.
The Nobel Prize committee recognized Bertozzi's pioneering advances on Wednesday, making her only the eighth woman to win the chemistry prize, at just 55 years old.
- Lego pieces -
Her journey began when she found she had a passion for organic chemistry, while taking pre-medicine courses at Harvard.
The subject is notoriously -- many say fiendishly -- difficult, but she credits an "amazing professor," the late David Evans, for bringing it to life -- and changing the course of her life.
"I said, forget the med school thing. I'm going to be a chemist," said Bertozzi, whose sister is a professor of applied mathematics, and father a retired professor of physics.
After completing her post-doctorate and joining the faculty at UC Berkeley, she wanted to take a closer look at glycans: complex carbohydrates, or sugars, located on the surface of cells, which "go through structural changes" when they become cancerous.
At the time, "there was no tool to image sugars, like in a microscope, for example," she said.
She had an idea that would require two chemical substances that fit together perfectly, like pieces of lego.
The first lego is fed to cells via a sugar. The cell metabolizes it and places it on the tip of the glycan. The second piece of lego, a fluorescent molecule, is injected into the body.
The two lego pieces click together, and voila: hidden glycans reveal themselves under a microscope.
This technique is inspired by "click chemistry" developed independently by Denmark's Morten Meldal and American Barry Sharpless -- Bertozzi's co-winners. But their discoveries relied on using copper as a catalyst, which is toxic to the body.
One of Bertozzi's great leaps was achieving the same type of ultra-efficient reaction without copper.
The other tour de force: making it all happen without wreaking havoc with other processes in the body.
"The beauty of it is that you can take the two Legos and click them together, even if they're surrounded by millions of other very similar plastic toys," she explained.
She coined the term "bioorthogonal chemistry," meaning a reaction that doesn't interfere with other biochemical processes. Perfecting the technique took 10 years.
- 'Cycle of science' -
Researchers are now leveraging these breakthroughs to develop cancer treatments.
Glycans on cancer cells "are able to hide the cancer cell from the immune system -- and so your body can't fight it, it can't see it," she explains.
Using bioorthogonal chemistry, "we made a new type of medicine, which basically acts like a lawnmower," says Bertozzi.
The first lego attaches to the cancer cell's surface, and the second, which clips onto it, is equipped with an enzyme that "mows off the sugars as if they're just grass, it cuts the grass and the sugars fall off," she says with a smile.
The drug is currently being tested in the early stages of a clinical trial.
Another company is seeking to use bioorthogonal chemistry to better target cancer treatment. The first lego piece is injected into a tumor, then a second, which carries the drug, attaches itself and acts only on its target.
"So that allows the oncologist to treat the tumor and kill the tumor without exposing the person's entire body to a toxic chemical," she says.
"What the future holds is hopefully an impact in human health," says Bertozzi. "But the people who decide that more so than myself, are the students and postdocs that join my lab."
Hundreds of them, current and former, filled her email box with messages of congratulations this morning.
"That really is the cycle of science -- it's being mentored and then mentoring" she adds. And "mentoring students gives you an opportunity to amplify the impact of your science."
P.Cavaco--PC